Altre lingue Longboard Pharmaceuticals, Inc.

Azioni

LBPH

US54300N1037

Tempo reale stimato Cboe BZX Altri mercati azionari 16:25:23 30/04/2024			Variaz. 5gg	Var. 1 gen.
21,46 ^USD	+1,08%		+7,46%	+261,24%

12/03	Longboard Pharmaceuticals, Inc. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI
16/01	LONGBOARD PHARMACEUTICALS, INC. : prospettiva positiva di Cantor Fitzgerald	ZM

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

LONGBOARD PHARMACEUTICALS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(4)	03/04
Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15	03/04
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)	02/04
Longboard Pharmaceuticals, Inc. announced that it has received $59.85 million in funding	26/03
Longboard Pharmaceuticals, Inc.(NasdaqGM:LBPH) added to S&P Pharmaceuticals Select Industry Index	18/03
Longboard Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	12/03
Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates	12/03
LONGBOARD PHARMACEUTICALS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(4)	04/03
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)	01/03
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)	02/02
Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences in February	01/02
LONGBOARD PHARMACEUTICALS ANNOUNCES CLOSING OF PUBLIC OFFERING OF COMMON STOCK AND FULL EXERCISE OF UNDERWRITERS OPTION TO PURCHASE ADDITIONAL SHARES	09/01
Longboard Pharmaceuticals Closes $242 Million Public Offering	08/01
Longboard Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares	08/01
Longboard Pharmaceuticals Prices $210 Million Stock Offering	04/01
Longboard Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock	04/01
LONGBOARD PHARMACEUTICALS ANNOUNCES POSITIVE TOPLINE DATA FROM THE PACIFIC STUDY, A PHASE 1B/2A CLINICAL TRIAL, FOR BEXICASERIN IN PARTICIPANTS WITH DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHIES	03/01
Longboard Pharmaceuticals Launching Share Offering	02/01
Longboard Pharmaceuticals Announces Commencement of Public Offering of Common Stock	02/01
Sector Update: Health Care Stocks Gain Late Afternoon	02/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Longboard Pharmaceuticals, Inc.

Azioni

LBPH

US54300N1037

Altre lingue

Filtri